发明名称 TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
摘要 Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen and immunosuppressants in order to generate tolerogenic immune responses against the antigen, such as the generation of antigen-specific CD8+ regulatory T cells.
申请公布号 US2016030555(A1) 申请公布日期 2016.02.04
申请号 US201514810466 申请日期 2015.07.27
申请人 Selecta Biosciences, Inc. 发明人 Kishimoto Takashi Kei;Fraser Christopher;Maldonado Roberto A.
分类号 A61K39/385;A61K39/35 主分类号 A61K39/385
代理机构 代理人
主权项 1. A method comprising: (A) administering to a subject a composition that comprises: (i) a first population of synthetic nanocarriers coupled to immunosuppressants, and (ii) MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen, wherein the composition is in an amount effective to generate antigen-specific CD8+ regulatory T cells in the subject; or (B) generating antigen-specific CD8+ regulatory T cells in a subject by administering a composition that comprises: (i) a first population of synthetic nanocarriers coupled to immunosuppressants, and (ii) MHC Class I-restricted and/or MHC Class II-restricted of an antigen; or (C) administering to a subject a composition according to a protocol that was previously shown to generate antigen-specific CD8+ regulatory T cells in one or more test subjects; wherein the composition comprises: (i) a first population of synthetic nanocarriers coupled to immunosuppressants, and (ii) MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen.
地址 Watertown MA US